TOGGLE MENU TOGGLE SEARCH HOME ABOUT US Our history Key milestones in the history of Freeline. 2011 - Professor Amit Nathwani’s work in collaboration with St. Jude Children’s Research Hospital (Memphis, Tennessee) published in the New England Journal of Medicine. His first haemophilia B patient dosed using a gene therapy approach showed very promising results with sustained long-term activity levels. - Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B - Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B 2015 - Freeline was founded with the focus of developing liver-directed gene therapies to deliver potential life-changing gene therapies to patients. Professor Amit Nathwani is Founder and CSO of Freeline. - Collaboration with St Jude Children’s Hospital signed. - Professor Nathwani’s AAV research team joins Freeline. 2016 Company formally launched. Management team with extensive broad experience put in place. Start-up based at the Royal Free Hospital in London, UK. 2017 The Freeline team expands further. Freeline moves headquarters to Stevenage, UK and in-house manufacturing facility is obtained. 2018 First patient in our lead programme in haemophilia B dosed with our next-generation gene therapy. First commercial manufacturing platform proven with first GMP batch, produced using our novel split-packaging system. 2019 - First patient in our second programme FLT190 for Fabry Disease dosed with our AAV gene therapy. - Our founder, Amit Nathwani, gives the plenary lecture at ASH (American Society for hematology). Additional clinical data for haemophilia B is presented at various key international conferences. 2020 Launched Freeline IPO in August (FRLN) Watch our mission video here. Read more Our team EXPLORE What makes us different EXPLORE Freeline at a glance EXPLORE We are looking for talented people to join the team SEARCH OPEN ROLES Get in touch T. Telephone: +44 (0)1438 906870 E. Email: contact@freeline.life Follow us on our social channels About us Innovation Patients & families Healthcare professionals Careers Investors Contact Terms of use Privacy Notice Accessibility Cookie Policy ©2021 Freeline